Lupin’s Q1 2023 results show a 16% profit growth and expanding margins, with revenue exceeding Rs 8,200 crore. Know the key highlights and what they mean for th
Tag: pharmaceutical industry
Lupin Q1 Results: Profit Surges 16% as Margins Expand
Lupin’s Q1 results show a 16% profit growth with revenue surpassing Rs 8,200 crore, highlighting the company’s expansion in the pharmaceutical industry.
The Impact of Trump’s Latest Tariffs on India’s Generic Medicines Industry
The latest tariffs imposed by the US on India’s generic medicines could have severe consequences for the Indian pharmaceutical industry and global healthcare.
Sun Pharma to Acquire US-Listed Organon in $12 Billion Deal
Sun Pharmaceutical Industries Ltd., an Indian multinational pharmaceutical company, is set to acquire US-listed Organon & Co. in a massive $12 billion deal that
